The 20 Best Acute Myeloblastic Leukemia without Maturation Doctors near New Hyde Park, NY

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration.

Jaime Andres Suarez Londono, MD, MBA, MS, is the associate director of the adult transplantation and cellular therapy program at Northwell Cancer Institute. After completing medical school in Medellin, Colombia, Dr. Londono did a residency at Columbia University's St Luke's Roosevelt Hospital and a fellowship at Albert Einstein College of Medicine. He then spent eight years as an assistant professor at NYU Langone's Perlmutter Cancer Center, where he held several leadership roles in the NYU Grossman Long Island School of Medicine, and in the stem cell transplant programI was inspired to study hematology, oncology and transplantation because advances in the field are bringing new hope and transforming the lives of our patients in a positive way, says Dr. Londono, who believes that the future of cancer treatment lies in personalized medicine approaches, such as immunotherapy and genetic therapy.Dr. Londono joined Northwell Cancer Institute to continue his research on improving outcomes and expanding access to life saving stem cell transplants and cellular therapies. My goal is to advance the field so we can overcome the challenges of limited donor compatibility and patient eligibility, ensuring more people benefit from transformative treatments, he says.Dr. Londono and his team have authored more than a dozen scientific papers, and his current work is gaining international recognition. Beyond research, he is passionate about public outreach through the American Society of Hematology, serving as co- director of the of Health Volunteers Overseas LATAM. He was honored with the Golden Apple Award from the American Society of Hematology's Health Volunteers Overseas program in recognition of his contributions to global health.Dr. Londono is the founder of a startup dedicated to alleviating physician shortages in the United States. With an eye toward the future, Dr. Londono recently earned an MBA and an MS in Healthcare Leadership from Cornell University. I wanted to study the global healthcare landscape how medicine is delivered in different countries, what lessons we can learn, and the nuances of biotech companies and market dynamics, he explains.Outside of medicine, Dr. Londono pursues his passion for cuisine by taking classes at the American Culinary Institute. Yet his most rewarding moments come at the bedside. My patients are truly 'patient' often spending three or four weeks in the hospital. It's incredibly inspiring to witness their resilience, commitment, and humility. They are the reason I work so hard. Dr. Londono is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy.

Peihong Hsu is a Pathologist and an Oncologist in New Hyde Park, New York. Dr. Hsu has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Lymphofollicular Hyperplasia, Leukocytosis, Non-Hodgkin Lymphoma, and Small Lymphocytic Lymphoma (SLL).

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Jessica Caro is a Hematologist Oncology specialist and a Hematologist in Lake Success, New York. Dr. Caro has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Multiple Myeloma, Febrile Neutropenia, Acute Myeloid Leukemia (AML), and Hemophagocytic Lymphohistiocytosis.

Shams Shakil, MD, PhD, MS, is an attending physician based at the Monter Cancer Center where he specializes in the treatment of patients with benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Shakil is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Shakil maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He earned his medical degree from Chittagong Medical College in Bangladesh, his PhD from Hiroshima University School of Medicine and his MS in Medical Informatics from the Oregon Health and Science University. His fellowship in Hematology/Oncology was completed at Brookdale University Hospital Center. Dr. Shakil has a research background in both surgical oncology and radiation oncology. He is an active member of the American Society of Hematology. Dr. Shakil is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Sickle Cell Disease, Anemia, Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Nouneh Gostanian is an Oncologist in Lake Success, New York. Dr. Gostanian is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Bone Marrow Aspiration, and Tissue Biopsy.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, Malignant Mixed Mullerian Tumor, and Salpingo-Oophorectomy.

Francis Arena is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Arena is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast.

Richard Forte is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Forte is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, and Essential Thrombocythemia.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Dennis L. Cooper, MD, is Chief, Bone Marrow Transplantation and Professor, Medicine at Montefiore Einstein. His clinical focus centers on treating patients with multiple myeloma, hodgkin's lymphoma, non-hodgkin's lymphoma including bone marrow transplantation and CAR T cell therapy. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Anne Renteria is a Hematologist in Mineola, New York. Dr. Renteria is rated as an Advanced provider by MediFind in the treatment of Acute Myeloblastic Leukemia without Maturation. Her top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.